Elanco Animal Health Inc (ELAN) Stock Price, Quote & News

Company Profile

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Crede...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 877 352 6261

Website: www.elanco.com

Address:

2500 Innovation Way, Greenfield, United States

Thestocktraderhubzee Jul. 3 at 10:56 AM

WATCHLIST JUL 03 2025. $STZ Needham Maintains Buy on Constellation Brands, Raises Price Target to $200 $ELAN Stifel Maintains Buy on Elanco Animal Health, Raises Price Target to $17 $TM Toyota Motor North America Invests More Than $50M In Construction Of New Amenities For Vehicle And Automotive Technology Testing And Development, Affirming Commitment To The Arizona Proving Grounds $WINT Windtree Therapeutics shares are trading higher after the company announced it was issued an istaroxime patent for the United States for Acute Heart Failure. $CRBG KNOT Offshore Partners shares are trading higher after the company announced that it will acquire the Daqing Knutsen from Knutsen NYK Offshore Tankers AS.

0 · Reply

JarvisFlow Jul. 2 at 5:23 PM

Stifel updates rating for Elanco Animal Health ( $ELAN ) to Buy, target set at 16 → 17.

0 · Reply

JarvisFlow Jun. 26 at 12:00 PM

William Blair updates rating for Elanco Animal Health ( $ELAN ) to Outperform.

0 · Reply

DonCorleone77 Jun. 12 at 8:23 PM

$ELAN Elanco's Zenrelia granted positive opinion by EU veterinary product committee Elanco announced that Zenrelia - ilunocitinib - has been granted a positive opinion by the European Medicines Agency's Committee for Veterinary Medicinal Products, or CVMP, paving the way for the product's marketing authorization in the European Union in the next 60 days. The CVMP recommended granting the marketing authorization based on the quality, safety and efficacy demonstrated in the data submitted and the favorable benefit-risk balance. Elanco expects to launch the product shortly after receiving marketing authorization with supply in the marketplace before the end of Q3. Zenrelia is already available in Brazil, Canada, Japan and the U.S., and the company expects additional approvals in Australia and the U.K. in 2025.

0 · Reply

SaylorsPonz Jun. 11 at 9:37 PM

is there a worse name than $ELAN ?

1 · Reply

macroaxis May. 30 at 3:45 AM

$ELAN - Elanco options price warning: put open interest is down to 3420.0 https://www.macroaxis.com/stock-options/ELAN/Elanco-Animal-Health?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

MyChicago May. 29 at 4:50 PM

$ZOMDF $WOOF $ELAN $CHWY

0 · Reply

DonCorleone77 May. 28 at 11:34 AM

$ELAN Elanco backs FY25 adjusted EPS view 80c-86c, consensus 84c Backs FY25 revenue view $4.51B-$4.58B, consensus $4.53B. Backs FY25 adjusted EBITDA view $830M-$870M.

0 · Reply

DonCorleone77 May. 28 at 11:33 AM

$ELAN Elanco still sees Q2 adjusted EPS 17c-21c, consensus 20c Still sees Q2 revenue $1.18B-$1.2B, consensus $1.19B. Still sees Q2 adjusted EBITDA $200M-$220M.

0 · Reply

DonCorleone77 May. 28 at 11:31 AM

$ELAN Elanco appoints Robert VanHimbergen as CFO Elanco appointed Robert VanHimbergen as EVP and CFO, effective July 7. VanHimbergen succeeds Todd Young, who will remain with the company as an advisor through August 31, to facilitate a smooth transition. VanHimbergen currently serves as the SVP and CFO of Hillenbrand. Prior to joining Hillenbrand, he spent 15 years at Johnson Controls. He previously held roles within Johnson Controls, including CFO of the $9B automotive interiors business in Shanghai, China, and led the battery division in Asia. Prior to Johnson Controls, VanHimbergen spent nearly a decade at PricewaterhouseCoopers.

0 · Reply

Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement

Jul 9, 2025, 10:01 AM EDT - 7 days ago

Elanco's dog flu vaccine gets USDA nod

Jul 9, 2025, 8:27 AM EDT - 7 days ago

Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection

Jul 2, 2025, 7:09 PM EDT - 14 days ago

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001

Jun 26, 2025, 2:38 PM EDT - 20 days ago

Elanco Animal Health Gets Its Bite Back, Pipeline Efforts Earn Praise

Jun 26, 2025, 1:00 PM EDT - 20 days ago

Elanco Releases 2024 Impact Report and Introduces New Framework

Jun 12, 2025, 4:17 PM EDT - 4 weeks ago

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP)

Jun 5, 2025, 7:45 AM EDT - 5 weeks ago

Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief

May 28, 2025, 7:25 AM EDT - 7 weeks ago

Elanco Appoints Robert (Bob) VanHimbergen as Chief Financial Officer

May 16, 2025, 8:00 AM EDT - 2 months ago

Elanco to Participate in the Upcoming Investor Conferences

May 12, 2025, 4:26 AM EDT - 2 months ago

Elanco: Deleveraging Takes Time

May 7, 2025, 12:52 PM EDT - 2 months ago

Elanco Animal Health Incorporated (ELAN) Q1 2025 Earnings Call Transcript

May 7, 2025, 11:03 AM EDT - 2 months ago

Animal Health Elanco Chirps A Solid Quarter Tempered By Soft Q2 EPS Guide

May 7, 2025, 6:27 AM EDT - 2 months ago

Elanco Animal Health Reports First Quarter 2025 Results

May 6, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect

May 5, 2025, 4:40 PM EDT - 2 months ago

Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal

May 5, 2025, 6:27 AM EDT - 2 months ago

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone; Accelerates Debt Paydown

TARS

May 4, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Reach Out

May 1, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Shareholders to Learn More About the Investigation

Apr 29, 2025, 10:00 AM EDT - 2 months ago

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Apr 24, 2025, 10:00 AM EDT - 2 months ago

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Apr 23, 2025, 1:16 PM EDT - 3 months ago

Trade Tracker: Sarat Sethi buys Zoetis and sells Elanco

ZTS

Apr 22, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect

Apr 22, 2025, 8:27 AM EDT - 3 months ago

Elanco's Breakthrough Treatment for Deadly Canine Parvovirus Has Saved Thousands of Puppies, Reaffirms Commitment to Increasing the Availability of Canine Parvovirus Monoclonal Antibody for Second Annual National Parvo Awareness Day

Apr 20, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation

Apr 17, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation

Apr 15, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Connect

Apr 13, 2025, 10:00 AM EDT - 3 months ago

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 10, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Stockholders to Learn More About the Investigation

Apr 10, 2025, 8:00 AM EDT - 3 months ago

Elanco Confirms Date and Conference Call for First Quarter 2025 Financial Results Announcement

Apr 8, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Investors to Inquire about Securities Investigation

Apr 6, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Reach Out

Mar 30, 2025, 10:00 AM EDT - 3 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Shareholders to Inquire about Securities Investigation

Mar 17, 2025, 4:17 PM EDT - 4 months ago

Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets

Mar 4, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Reach Out

Feb 25, 2025, 1:38 PM EST - 5 months ago

Elanco Animal's Outlook Lags Street Expectations But Analyst Sees Time For Elanco's Commercial Investment To Payoff

Feb 25, 2025, 10:59 AM EST - 5 months ago

Elanco Animal Health Incorporated (ELAN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 7:05 AM EST - 5 months ago

Elanco Enters Agreement with Medgene to Commercialize Highly Pathogenic Avian Influenza Vaccine in Dairy Cattle

Feb 25, 2025, 7:05 AM EST - 5 months ago

Elanco Animal Health Reports Fourth Quarter and Full Year 2024 Results

Feb 21, 2025, 8:00 AM EST - 5 months ago

Elanco to Participate in Upcoming Investor Conferences

Feb 20, 2025, 8:27 AM EST - 5 months ago

Elanco Launches Pet Protect™ From the Makers of Advantage®: Veterinarian-Formulated Supplements for Complete Pet Wellness

Feb 13, 2025, 4:29 PM EST - 5 months ago

Elanco Reinforces Commitment to Veterinary and Pet Owner Education

Feb 4, 2025, 8:00 AM EST - 5 months ago

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2024 Financial Results Announcement

Jan 27, 2025, 8:06 AM EST - 6 months ago

Meet the Faces of Zen: Elanco's Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal

Jan 15, 2025, 6:42 AM EST - 6 months ago

Elanco Animal Health: Building On Success

Dec 19, 2024, 11:07 AM EST - 7 months ago

Elanco to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 6, 2024, 11:51 AM EST - 7 months ago

ELAN Deadline Today: Rosen Law Firm Urges Elanco Animal Health Incorporated (NYSE: ELAN) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Thestocktraderhubzee Jul. 3 at 10:56 AM

0 · Reply

JarvisFlow Jul. 2 at 5:23 PM

Stifel updates rating for Elanco Animal Health ( $ELAN ) to Buy, target set at 16 → 17.

0 · Reply

JarvisFlow Jun. 26 at 12:00 PM

William Blair updates rating for Elanco Animal Health ( $ELAN ) to Outperform.

0 · Reply

DonCorleone77 Jun. 12 at 8:23 PM

0 · Reply

SaylorsPonz Jun. 11 at 9:37 PM

is there a worse name than $ELAN ?

1 · Reply

macroaxis May. 30 at 3:45 AM

$ELAN - Elanco options price warning: put open interest is down to 3420.0 https://www.macroaxis.com/stock-options/ELAN/Elanco-Animal-Health?utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

MyChicago May. 29 at 4:50 PM

$ZOMDF $WOOF $ELAN $CHWY

0 · Reply

DonCorleone77 May. 28 at 11:34 AM

$ELAN Elanco backs FY25 adjusted EPS view 80c-86c, consensus 84c Backs FY25 revenue view $4.51B-$4.58B, consensus $4.53B. Backs FY25 adjusted EBITDA view $830M-$870M.

0 · Reply

DonCorleone77 May. 28 at 11:33 AM

$ELAN Elanco still sees Q2 adjusted EPS 17c-21c, consensus 20c Still sees Q2 revenue $1.18B-$1.2B, consensus $1.19B. Still sees Q2 adjusted EBITDA $200M-$220M.

0 · Reply

DonCorleone77 May. 28 at 11:31 AM

0 · Reply

OptionRunners May. 23 at 4:49 PM

$ELAN Buyer of the June 20th $13 puts (ITM) 1,648 times for $0.76-$0.80

0 · Reply

Estimize May. 13 at 10:00 AM

Wall St is expecting 0.22 EPS for $ELAN Q2 [Reporting 08/11 BMO] http://www.estimize.com/intro/elan?chart=historical&metric_name=eps&utm_co

0 · Reply

Quantumup May. 12 at 3:54 PM

BofA Asks and Answers: on a, "Potential reset / reduction of China tariffs: Who stands to benefit the most? — Biggest beneficiaries: TMO [Buy-$545], AVTR , DHR [Buy-$230], RVTY [Buy-$116], $MTD, $ILMN [Underperform-$70]" $ELAN BofA said in its note:

0 · Reply

Armymike1981 May. 10 at 2:38 PM

$ELAN this movement is only the beginning !!! Up until now Zoetis was selling products that were only in their arsenal … now with zenrelia, Quattro and gallaprant… their reign is over!! I would be shorting Zoetis from this point!

0 · Reply

JarvisFlow May. 8 at 1:50 PM

Stifel updates rating for Elanco Animal Health ( $ELAN ) to Buy, target set at 13 → 15.

0 · Reply

SwanStefan May. 8 at 10:54 AM

$QVCGB $QRTEB $GOCO $HALO $ELAN

0 · Reply

LewisDaKat May. 7 at 6:55 PM

$ELAN News out Connection, Joy, Gizmo: Dr. Joya Griffin https://marketwirenews.com/news-releases/connection-joy-gizmo-dr-joya-griffin-5415388920579925.html $ELAN

0 · Reply

DimebagDarrell_ May. 7 at 6:23 PM

$ELAN We are OUT! Love trading this stock. We’ll be back when the time is right.

0 · Reply

lecorb May. 7 at 12:45 PM

$ELAN https://seekingalpha.com/news/4443040-elanco-stock-spikes-q1-beat?mailingid=39751587&messageid=2900&serial=39751587.362&source=email_2900&utm_campaign=rta-stock-news&utm_content=link-3&utm_medium=email&utm_source=seeking_alpha&utm_term=39751587.362

0 · Reply

OpenOutcrier May. 7 at 12:30 PM

$ELAN (+8.8% pre) Elanco (NYSE:ELAN) Beats Q1 Sales Targets, Full-Year Outlook Slightly Exceeds Expectations https://ooc.bz/l/63797

0 · Reply

RMAW May. 7 at 12:29 PM

$ELAN BULLISH LOOONG TERM!!!!

0 · Reply

lecorb May. 7 at 10:56 AM

$ELAN Elanco Non-GAAP EPS of $0.37 beats by $0.07, revenue of $1.19B beats by $20M

0 · Reply

Market Cap	7.26B
Revenue (ttm)	4.44B
Net Income (ttm)	338.00M
EPS (ttm)	N/A
PE Ratio	15.84
Forward PE	17.81
Profit Margin	7.61%
Debt to Equity Ratio	0.69

Volume	3,796,600
Avg Vol	6,006,836
Day's Range	N/A - N/A
Shares Out	496.65M
Stochastic %K	18%
Beta	1.67
Analysts	Strong Sell
Price Target	$14.72